BROWSE BY TOPIC
Stories of Interest
- White House Now Doesn’t Dispute Details of Trump's Call with Army Widow
- Goldman Sachs’ Lloyd Blankfein Just Threw Some Serious Brexit Shade
- Guggenheim Partners ‘Bank Wrecker’ Could Get $100Mn Exit Package
- Proposed Arbitration Rule Change: For Customers Dealing with an Inactive Firm or Associated Person
- This Family Bet It All on Bitcoin
- Clearinghouses Pass CFTC Liquidity Stress Tests
- President Trump Admits He’s Trying to Kill Obamacare. That’s Illegal.
- Trump Plunges Down List of ‘America’s Richest’
- Is Trump’s “Foreclosure King” in Over His Head?
- FBI Arrests NCAA Basketball Coaches and Adidas Rep in Bribery Probe Involving Recruitment
- Equifax CEO Steps Down Amid Hacking Scandal
- Litigation Costs to Rub Salt in RBS Investor Wounds
- RIAs Poised to Land Wirehouse Recruits - Dan Jamieson
- Citibank and U.K. Affiliate to Pay $550K Penalty for Swap Data Reporting Violations - CFTC
- AIG to Restructure into 3 New Units, Marking CEO's First Big Move
- Accounting Firm Deloitte Says It Suffered Cyberattack (subsc reqd)
- Upcoming FINRA Board Meeting and FINRA360 Update
- Elizabeth Warren Lifts Hold on Trump DOJ Antitrust Nominee
- Bigger Mergers Narrow Indy Reps' Options, Alter IBD Channel - Dan Jamieson
- Dentons to Merge with U.K.'s Murray & Spens
We seek to provide information, insights and direction that may enable the Financial Community to effectively and efficiently operate in a regulatory risk-free environment by curating content from all over the web.
Stay Informed with the latest fanancialish news.
NEWSLETTERS & ALERTS
'Pharma Bro' Martin Shkreli Guilty of Securities Fraud
[Photo: Screen Grab from CBS News]
A federal jury found Martin Shkreli - aka 'Pharm Bro' - guilty on 3 counts of securities fraud, but acquitted him on 5 other counts. He faces up to 20 years in prison on the most serious charges, though he's likely to get much less.
Shkreli was charged with 8 separate counts of securities fraud, conspiracy to commit securities fraud and wire fraud, for his role managing a pair of hedge funds - MSMB Capital Management and MSMB Healthcare - between 2009 and 2014.
The government had accused Shkreli of defrauding investors and lying about the funds' performance, and that he later stole more than $11 million from Retrophin, a company he founded and brought public, to pay back those investors. However, the case was tricky for prosecutors because investors, some wealthy financiers from Texas, condeded at the trial that Shkreli's scheme actually made them richer, in some cases doubling or even tripling their money on his company's stock when it went public. The defense portrayed them as spoiled "rich people" who were the ones doing the manipulating.
"Who lost anything? Nobody," defense attorney Brafman said in his closing argument. Some investors had to admit on the witness stand that partnering with Shkreli was "the greatest investment I've ever made," he added.
Federal prosecutors responded: “Just because the defendant got lucky and Retrophin became a success years later” that doesn’t excuse fraud. “Martin Shkreli doesn’t think the rules doesn’t apply to him, that the law doesn’t apply to him unfortunately for him, it does.”
Shkreli and his lawyer, Ben Brafman, were thrilled by the verdict. "We think verdict as it now stands, will permit this court to impose very lenient sentence," Brafman said - which Shkreli interpreted to mean that he may serve only a couple of months in "Club Fed."